Optimización del tratamiento inmunomodulador con azatioprina o 6-mercaptopurina en pacientes con enfermedad inflamatoria intestinal

Some clinical variables such as phenotipe of disease, the use of full doses of thiopurinic drug from the be-ginning and co-treatments could had a notable influence in the side effects of the IST and thus in effectiveness of thiopurinic treatment in IBD.